Common Stock, Shares, Outstanding of Aquestive Therapeutics, Inc. from 30 Sep 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Aquestive Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 30 Sep 2018 to 31 Dec 2025.
  • Aquestive Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 122,044,299, a 34% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Aquestive Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 122,044,299 +30,630,557 +34% 31 Dec 2025 10-K 04 Mar 2026 2025 FY
Q3 2025 121,658,113 +30,479,920 +33% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 99,353,270 +8,293,510 +9.1% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 99,317,153 +8,838,422 +9.8% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 91,413,742 +22,880,657 +33% 31 Dec 2024 10-K 04 Mar 2026 2025 FY
Q3 2024 91,178,193 +24,437,428 +37% 30 Sep 2024 10-Q 04 Nov 2024 2024 Q3
Q2 2024 91,059,760 +29,443,801 +48% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 90,478,731 +34,556,370 +62% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 68,533,085 +13,705,351 +25% 31 Dec 2023 10-K 05 Mar 2025 2024 FY
Q3 2023 66,740,765 +12,888,639 +24% 30 Sep 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 61,615,959 +8,271,970 +16% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 55,922,361 +14,301,973 +34% 31 Mar 2023 10-Q 02 May 2023 2023 Q1
Q4 2022 54,827,734 +13,598,998 +33% 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q3 2022 53,852,126 +13,768,881 +34% 30 Sep 2022 10-Q 01 Nov 2022 2022 Q3
Q2 2022 53,343,989 +14,775,747 +38% 30 Jun 2022 10-Q 02 Aug 2022 2022 Q2
Q1 2022 41,620,388 +5,379,030 +15% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 41,228,736 +6,659,482 +19% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 40,083,245 +6,463,449 +19% 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 38,568,242 +4,951,641 +15% 30 Jun 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 36,241,358 +2,658,662 +7.9% 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 34,569,254 +1,006,369 +3% 31 Dec 2020 10-K 08 Mar 2022 2021 FY
Q3 2020 33,619,796 +8,576,832 +34% 30 Sep 2020 10-Q 04 Nov 2020 2020 Q3
Q2 2020 33,616,601 +8,593,941 +34% 30 Jun 2020 10-Q 04 Aug 2020 2020 Q2
Q1 2020 33,582,696 +8,607,557 +34% 31 Mar 2020 10-Q 05 May 2020 2020 Q1
Q4 2019 33,562,885 +8,605,576 +34% 31 Dec 2019 10-K 09 Mar 2021 2020 FY
Q3 2019 25,042,964 +100,779 +0.4% 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 25,022,660 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 24,975,139 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 24,957,309 31 Dec 2018 10-K 11 Mar 2020 2019 FY
Q3 2018 24,942,185 30 Sep 2018 10-Q 06 Nov 2018 2018 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.